• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Botanical Supplement Improves Skin Barrier Function and Redness in Clinical Trial

by
November 20, 2026
in Health
Reading Time: 6 mins read
0
Botanical Supplement Improves Skin Barrier Function and Redness in Clinical Trial

Botanical Supplement Improves Skin Barrier Function and Redness in Clinical Trial

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A dietary supplement combining extracts of Cistanche deserticola and Osmanthus fragrans significantly enhanced cutaneous barrier integrity, reduced moisture loss, and improved several aging-related skin parameters over a four-week period, according to a randomized, double-blind, placebo-controlled clinical investigation. Cutaneous aging represents an intricate biological process driven by the simultaneous interplay of intrinsic chronological decay and extrinsic environmental insults, predominantly ultraviolet radiation and oxidative stress. Within skin tissue, an overaccumulation of reactive oxygen species overwhelms endogenous cellular defenses, causing macromolecular damage, senescence in epidermal keratinocytes and dermal fibroblasts, and structural degradation across extracellular matrix proteins. Clinically, this progressive deterioration compromises barrier competence, exacerbates trans-epidermal water loss, accelerates wrinkle formation, and promotes uneven pigmentation, erythema, and dullness. While individual pharmacological evaluations have documented the free-radical scavenging and anti-inflammatory properties of both botanical species, their combined oral influence on human dermatological parameters had previously remained unexamined in formal human testing.

To evaluate whether this specific dual-botanical combination could measurably ameliorate cutaneous barrier decline and visible aging signs, researchers organized a four-week clinical trial centered on primary and secondary biophysical endpoints. The primary clinical outcome pre-specified in the protocol was the quantitative change in trans-epidermal water loss from baseline to day twenty-eight across distinct anatomical regions. Water vapor dissipation across the stratum corneum serves as a standard non-invasive physiological marker of cutaneous barrier function, with diminished values directly indicating superior barrier impermeability and enhanced hydration retention. Secondary evaluation criteria included surface acidity, surface gloss, high-frequency ultrasonic assessment of epidermal and dermal layer thickness, and objective spectrophotometric determination of skin chromaticity, focusing specifically on lightness and erythema. By measuring both the sun-exposed cheek and the relatively shielded inner forearm, the study design aimed to establish whether systemic dietary administration could exert measurable benefits across differing anatomical sites.

Participant recruitment and screening were conducted under rigorous clinical criteria approved by an institutional ethics committee. The investigative team enrolled forty-nine healthy Chinese female volunteers aged twenty-six to forty-five years, characterized by atopic and phlegm-dampness constitutional profiles, self-perceived skin sensitivity confirmed via a standardized ten-percent lactic acid stinging test, and baseline facial and forearm erythema scored between grades two and five. Candidates were excluded if they presented with chronic dermatological illnesses, recent aesthetic interventions within six months, participation in another clinical investigation within three months, overt scarring, abnormal pigmentation, active infections, or if they were pregnant or lactating. One participant subsequently discontinued participation due to personal circumstances, yielding an evaluable cohort of forty-eight women. The experimental group had an average age of 38.54 years, while the placebo cohort recorded an average age of 38.46 years, demonstrating baseline demographic balance between both treatment arms.

The study implemented rigorous methodological controls to prevent bias across enrollment, treatment allocation, and data recording. Eligible volunteers were randomized on a one-to-one basis using an independent computer-generated allocation schedule prepared by an external statistician. Product distribution employed sequentially numbered, visually indistinguishable sealed sachets containing identical powders to guarantee thorough allocation concealment from participants, investigators, and outcome technicians throughout the trial duration. The experimental product provided daily dosages of fifty milligrams of Cistanche deserticola extract and three hundred milligrams of Osmanthus fragrans extract per 1.5-gram sachet, blended with gamma-cyclodextrin, erythritol, and lemon powder excipients. Participants in the control group received matching sachets wherein active botanicals were substituted entirely by additional gamma-cyclodextrin. Subjects ingested two sachets daily for twenty-eight consecutive days, with therapeutic compliance verified through returned empty container tallies, where taking at least eighty percent of scheduled sachets was required for compliance analysis.

Biophysical measurements were conducted under standardized environmental conditions at baseline and at the conclusion of the twenty-eight-day intervention using specialized dermatological diagnostic equipment. Trans-epidermal water loss was quantified using a Tewameter probe placed precisely on predetermined coordinates of the cheek and inner forearm. Cutaneous surface pH was evaluated on the cheek utilizing an automated glass-electrode surface pH meter. Skin surface reflectivity and glossiness were documented on both anatomical sites using a dedicated glossmeter. Furthermore, tissue architecture was profiled on the cheek via high-frequency diagnostic ultrasound imaging to resolve distinct epidermal and dermal thickness measurements in micrometers. Surface chromaticity was assessed by recording lightness and redness coordinates through spectrophotometry on the forearm and standardized digital image analysis under controlled cross-polarized illumination across the facial area.

Statistical evaluation of the dataset applied both within-group and between-group testing frameworks to evaluate treatment efficacy. For within-group longitudinal comparisons between baseline and day twenty-eight, researchers evaluated data distribution normality using the Shapiro-Wilk test alongside graphical quantile-quantile plots and histograms. Variables conforming to normal distributions were analyzed using two-tailed paired t-tests, whereas parameters violating normality assumptions in either cohort were evaluated across both groups via Wilcoxon signed-rank non-parametric tests. To rigorously evaluate the statistical superiority of the active botanical formulation over the inactive placebo, researchers conducted analysis of covariance on each outcome variable, incorporating the baseline day-zero measurement as an analytical covariate to adjust for minor initial variances, establishing statistical significance at an alpha threshold of 0.05.

Assessment of the trial’s primary outcome demonstrated substantial enhancements in epidermal barrier performance among participants consuming the botanical supplement. Following twenty-eight days of supplementation, subjects in the active product group exhibited a statistically significant 8.53 percent decrease in cheek trans-epidermal water loss and a 5.37 percent reduction on the inner forearm compared to their respective baseline readings. In contrast, the placebo group demonstrated no significant longitudinal changes across either anatomical site. Comparative analysis of covariance confirmed that the experimental botanical treatment produced significantly greater reductions in moisture loss relative to placebo on the cheek, with a ninety-five percent confidence interval ranging from negative 1.919 to negative 0.326 and a p-value of 0.007. Similarly, barrier restoration on the inner forearm yielded a statistically superior reduction relative to control, with a confidence interval between negative 0.872 and negative 0.228 and a p-value of 0.001.

Secondary structural evaluations performed with high-frequency cutaneous ultrasound revealed notable alterations in both superficial and deeper cutaneous compartments. Subjects receiving the active botanical supplement exhibited a 16.1 percent reduction in epidermal thickness from baseline, alongside a 7.59 percent expansion in dermal layer thickness at day twenty-eight. Participants in the control cohort displayed minimal alterations, registering non-significant shifts of 3.8 percent in the epidermis and 0.24 percent in the dermis. Between-group covariance comparisons established that the reduction in epidermal thickness favored the experimental intervention significantly, recording an estimated difference interval between negative 23.895 and negative 3.414 with a p-value of 0.010. Concurrently, dermal augmentation was significantly greater in the active group than in the placebo arm, characterized by a ninety-five percent confidence interval of 22.171 to 140.888 and a p-value of 0.008.

Surface optical properties, including glossiness and chromaticity, showed uniform positive responses to the four-week botanical regimen. On the cheek, skin glossiness expanded by 11.95 percent in the active cohort compared to a negligible 0.64 percent increase in the placebo arm, a difference confirmed significant by analysis of covariance with a p-value under 0.001. Forearm glossiness likewise improved by 4.41 percent in the active group versus 0.77 percent in the control group. Chromatic analysis demonstrated substantial brightening alongside marked mitigation of cutaneous erythema. Cheek skin lightness increased by 2.22 percent under active treatment versus 0.10 percent under placebo, while redness scores fell by 7.74 percent on the cheek and 8.55 percent on the forearm among active recipients, compared to minimal alterations of negative 0.13 percent and positive 1.00 percent in the placebo cohort, with both between-group differences reaching statistical significance.

Facial surface pH also exhibited a statistically significant alteration, rising by 7.25 percent following active botanical consumption compared to an increase of only 0.48 percent among control participants, yielding an adjusted between-group confidence interval of 0.191 to 0.403 and a p-value under 0.001. The investigators noted that while skin barrier optimization typically associates with an acidic surface mantle, this upward adjustment may represent normalization among volunteers presenting with unusually low baseline values, or alternatively reflect modifications in sebum composition, sweat output, or natural moisturizing factor concentrations. Throughout the entire twenty-eight-day intervention, comprehensive clinical assessments, dermatological examinations, and subject questionnaires recorded no adverse events or tolerability concerns in either group, corroborating the preliminary clinical safety profile of the combined botanical extract at the administered dosage.

The study authors contextualized their observations within the documented pharmacological properties of the botanical components. Phenylethanoid glycosides, prominently including echinacoside and verbascoside from Cistanche deserticola, are recognized cellular antioxidants known to activate nuclear factor erythroid 2-related factor pathways and suppress cellular senescence. Likewise, bioactive flavonoids and phenylethanoid constituents extracted from Osmanthus fragrans flowers have demonstrated capacity in laboratory studies to scavenge reactive oxygen species and upregulate type one collagen gene expression in dermal fibroblasts. The observed reduction in epidermal thickness coupled with decreased redness values suggests a resolution of subclinical micro-inflammation and restoration of cellular homeostasis rather than structural atrophy, while dermal expansion aligns with potential extracellular matrix reinforcement.

Despite these encouraging quantitative outcomes, the study authors emphasized critical methodological limitations that warrant careful, conservative interpretation. Foremost among these considerations was the absence of prospective registration in an accessible public clinical trials registry prior to participant enrollment, which the researchers acknowledged as a formal methodological limitation despite pre-specifying their primary outcome within the ethics-approved trial protocol. Additionally, the intervention span was restricted to twenty-eight days without an extended follow-up or withdrawal monitoring phase, leaving the durability and persistence of the improvements unverified. Finally, the investigation was conducted at a single testing center and enrolled a relatively small, homogeneous demographic cohort restricted to healthy adult Chinese females. Consequently, the authors concluded that while these clinical results provide promising preliminary evidence of enhanced skin barrier competence and chromatic uniformity, definitive confirmation of long-term anti-aging efficacy will require larger, multi-center trials incorporating direct molecular and structural cutaneous biomarkers.

Subject of Research: Clinical evaluation of Cistanche deserticola and Osmanthus fragrans extracts on skin barrier function and aging parameters

Article Title: A randomized, placebo-controlled, double-blinded clinical trial: evaluating the effects of Cistanche deserticola Y.C.Ma and Osmanthus fragrans (Thunb.) Lour. extracts on aging-related skin conditions in healthy women

Article References: Zhang, Y., Dai, D., Li, Y., Huang, Q., Wang, Z., Shi, B., & Lu, B. (2026). A randomized, placebo-controlled, double-blinded clinical trial: evaluating the effects of Cistanche deserticola Y.C.Ma and Osmanthus fragrans (Thunb.) Lour. extracts on aging-related skin conditions in healthy women. Frontiers in Medicine, 13, Article 1983455. https://doi.org/10.3389/fmed.2026.1983455

Image Credits: AI Generated

DOI: 10.3389/fmed.2026.1983455

Keywords: Cistanche deserticola, Osmanthus fragrans, skin barrier function, trans-epidermal water loss, clinical trial, skin aging, dermatology, nutraceuticals, skin hydration, dermal thickness, epidermal thickness, skin chromaticity, erythema, phenylethanoid glycosides, botanical extracts, placebo-controlled trial, skin glossiness

News Source: Ophelia Keating. (November 20, 2026). Botanical Supplement Improves Skin Barrier Function and Redness in Clinical Trial. Scienmag.

Tags: botanical extractsCistanche deserticolaclinical trialdermal thicknessDermatologyepidermal thicknesserythemanutraceuticalsOsmanthus fragransphenylethanoid glycosidesplacebo-controlled trialskin agingskin barrier functionskin chromaticityskin glossinessskin hydrationtrans-epidermal water loss
Share12Tweet7Share2ShareShareShare1

Related Posts

Hospital Infection Control Training Shows Gaps Across Low- and Middle-Income Countries

Hospital Infection Control Training Shows Gaps Across Low- and Middle-Income Countries

November 20, 2026
Stroke Lesion Location and Unaffected Brain Inhibition Predict Motor Recovery Outcomes

Stroke Lesion Location and Unaffected Brain Inhibition Predict Motor Recovery Outcomes

November 20, 2026

Most South African Women with Genital Schistosomiasis Symptoms Prefer Biomedical Care

November 20, 2026

Dual First-Trimester Thyroid Antibodies Linked to Later Gestational Thyroid Dysfunction

November 20, 2026

POPULAR NEWS

  • Wild Custard Apple Leaf Size and Chemistry Vary Across Ghana Ecologies

    Wild Custard Apple Leaf Size and Chemistry Vary Across Ghana Ecologies

    29 shares
    Share 12 Tweet 7
  • Zanubrutinib Outperforms Older BTK Inhibitors in B Cell Lymphoma Meta-Analysis

    29 shares
    Share 12 Tweet 7
  • Child Care Pressures Spur Female Entrepreneurship Across Urban China via Reduced Compensation

    29 shares
    Share 12 Tweet 7
  • Pandemic Widened Physical Health Gap Between High and Low Earners in Germany

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Matrix-Free Mixture Model Accelerates High-Dimensional Biomedical Clustering and Characterization

Urinary Proteomics Reveals Staged Heme Stress in Neonatal Hypoxic-Ischemic Encephalopathy

Hospital Infection Control Training Shows Gaps Across Low- and Middle-Income Countries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.